Henry Schein management check

HSIC · Health Care · Health Care Distributors · CEO Mr. Bergman

Filings as of

46
Management score, ranked 448th of 487 · 55th of 60 in Health Care1 good · 4 to watch · 1 flaggedStrongest: dilution · Weakest: CEO cost · Best and worst run in Health Care →

Closest peers in Health Care Distributors

  1. 46CAHCardinal Health81
  2. 144MCKMcKesson72
  3. 268CORCencora63
  4. 443ILMNIllumina, Inc.47
  5. 447CNCCentene Corporation47
  6. 448HSICHenry Schein46

The seven checks

  • Watch

    Have owners done well?

    Trailed its chosen peersOwners$116Peers$144

    What $100 became since fiscal 2021

    2633rd
    Detail

    $100 invested at the start of fiscal 2021 grew to $116, against $144 for the peer group the company picked itself.

  • Watch

    Does pay follow performance?

    Pay only loosely tracked returns20212025

    Pay actually paid $100 value, each on its own scale

    5113th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.01 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Watch

    What does the CEO cost owners?

    2.9% of net income

    $12.0m pay · $419.0m net income, FY2025

    0.1%1%3%10%
    1220th
    Detail

    $12.0m of reported pay in fiscal 2025, against $419.0m of net income.

  • n/a

    Do they own the stock?

    No recent CEO filing
    ——

    No open-market insider buying or selling in the last six months.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 142m2025 · 122m

    Diluted shares −3.9% a year; flagged above +2%

    0%10%20%

    Stock pay 0.3% of revenue

    9988th
    Detail

    Diluted shares changed -3.9% a year over the last three fiscal years. Stock-based pay was 0.3% of revenue in the latest year.

  • Watch

    Is leadership stable?

    13 leadership filings in 3 years

    13 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Mr. Bergman

    6038th
    Detail

    CEO in the pay table: Mr. Bergman. 13 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Flag

    Are the books clean?

    Red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 1Late filings
    • 010-K amended
    307th
    Detail

    1 late-filing notice since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed April 8, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$14.1m$28.3m$10020212022202320242025$116$144

Pay tied most to Non-GAAP EPS

Other key measuresAdjusted EPSRevenuesAdjusted Operating IncomeReturn on Invested Capital

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Mr. Bergman$12.0m$9.8m$3.3m$116$144$419.0m
2024—$11.6m$7.9m$3.2m$107$126$398.0m
2023—$10.0m$4.9m$2.8m$115$122$436.0m
2022—$8.3m$10.0m$2.9m$121$120$566.0m
2021—$10.8m$28.3m$3.9m$114$124$660.0m

Insiders and the CEO's stakeQuiet

No open-market insider buying or selling in the last six months.

Open-market trades by officers and directors since May 21, 2026.

Leadership and governance on file

20222023202420252026Leadership 19Red flags 1Votes 5
All 20 filings

Latest shareholder vote results: May 22, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $2.4bn returned to owners in buybacks and dividends, 96% of net income, and $249.0m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$425.0m$850.0m20212022202320242025Shares142m138m132m128m122m
Show the figures
Fiscal year20212022202320242025
Revenue$12.4bn$12.6bn$12.3bn$12.7bn$13.2bn
Net income$660.0m$566.0m$436.0m$398.0m$419.0m
Stock-based pay$78.0m$54.0m$39.0m$39.0m$39.0m
Buybacks$401.0m$485.0m$250.0m$385.0m$850.0m
Dividends—————
Diluted shares142m138m132m128m122m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.